Edition:
United Kingdom

Intellipharmaceutics International Inc (IPCI.OQ)

IPCI.OQ on NASDAQ Stock Exchange Capital Market

0.27USD
20 Aug 2018
Change (% chg)

$-0.01 (-4.30%)
Prev Close
$0.28
Open
$0.27
Day's High
$0.28
Day's Low
$0.26
Volume
16,117
Avg. Vol
39,361
52-wk High
$1.25
52-wk Low
$0.25

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 May '18 0.58 -0.068
Feb '18 0.33 -0.091
FY 2017 Nov '17 1.08 -0.076
Aug '17 1.19 -0.083
May '17 2.00 -0.059
Feb '17 1.24 -0.066
FY 2016 Nov '16 0.57 -0.134
Aug '16 0.55 -0.074
May '16 0.56 -0.081
Feb '16 0.57 -0.087
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Aug-18 1 1.89 1.89 1.89 8.07
Quarter Ending Nov-18 1 3.89 3.89 3.89 8.04
Year Ending Nov-18 1 7.00 7.00 7.00 28.84
Year Ending Nov-19 1 9.25 9.25 9.25 42.77
Earnings (per share)
Quarter Ending Aug-18 1 -0.04 -0.04 -0.04 0.09
Quarter Ending Nov-18 1 0.00 0.00 0.00 0.09
Year Ending Nov-18 1 -0.19 -0.19 -0.19 0.31
Year Ending Nov-19 1 -0.10 -0.10 -0.10 0.50
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.93 32.76
P/E High - Last 5 Yrs. -- 40.66 45.44
P/E Low - Last 5 Yrs. -- 23.69 24.26
Beta 1.09 0.90 0.89
Price to Sales (TTM) 7.81 3.94 5.75
Price to Book (MRQ) 42.05 4.88 5.00
Price to Tangible Book (MRQ) 42.26 5.70 6.57
Price to Cash Flow (TTM) -- 22.85 23.29
% Owned Institutions 0.49 1.23 2.21

Dividends

  Company industry sector
Dividend Yield -- 1.57 1.51
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.35 5.22
Payout Ratio(TTM) -- 45.85 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 259.96 2.27 8.01
Sales (TTM) vs TTM 1 Yr. Ago 55.26 4.77 5.64
Sales - 5 Yr. Growth Rate 34.96 9.94 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 26.47 17.61 20.60
EPS (TTM) vs TTM 1 Yr. Ago 10.74 -- --
EPS - 5 Yr. Growth Rate -- 9.75 10.66
Capital Spending - 5 Yr. Growth Rate 14.48 15.37 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.79 2.15 2.22
Current Ratio (MRQ) 0.90 2.94 3.03
LT Debt to Equity (MRQ) 0.00 10.03 12.51
Total Debt to Equity (MRQ) 157.71 14.07 16.85
Interest Coverage (TTM) -67.27 35.77 32.63

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 41.05 54.71 54.37
Gross Margin - 5 Yr. Avg. -- 52.10 52.17
EBITD Margin (TTM) -207.45 -- --
EBITD - 5 Yr. Avg -211.00 18.48 10.65
Operating Margin (TTM) -216.71 14.31 4.32
Operating Margin - 5 Yr. Avg. -224.23 14.43 6.06
Pre-Tax Margin (TTM) -225.17 14.80 5.18
Pre-Tax Margin - 5 Yr. Avg. -233.31 14.82 6.49
Net Profit Margin (TTM) -225.17 11.05 1.48
Net Profit Margin - 5 Yr. Avg. -233.31 11.12 2.77
Effective Tax Rate (TTM) -- 23.22 23.11
Effective Tax Rate - 5 Yr. Avg. -- 23.48 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 952,976,482 860,375,103
Net Income/Employee (TTM) -- 112,117,219 101,207,184
Receivable Turnover (TTM) 6.35 5.72 5.87
Inventory Turnover (TTM) -- 2.63 3.41
Asset Turnover (TTM) 0.75 0.96 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -169.32 11.58 11.13
Return on Assets - 5 Yr. Avg. -144.35 12.95 12.40
Return on Investment (TTM) -1,305.65 15.07 14.61
Return on Investment - 5 Yr. Avg. -462.28 16.90 16.13
Return on Equity (TTM) -- 16.59 16.33
Return on Equity - 5 Yr. Avg. -- 17.97 17.39
  1 Year 3 Year 5 Year
Sales % -45.11 13.73 34.96
EPS (TTM) % -21.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Intellipharmaceutics International Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.